Abstract
Subcutaneous Omacetaxine in Chronic or Accelerated Chronic Myeloid Leukemia Resistant to Two or More Tyrosine-Kinase Inhibitors Including Imatinib,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have